BlackRock’s active equity platform includes over 40 mutual funds and 16 ETFs, striving for both competitive performance and low fees. We develop strategies to help your clients achieve their financial goals, whatever they may be.
Get started with these investment ideas from BlackRock’s active equity platform to help your clients reach their goals.
The Morningstar RatingTM for funds, or "star rating", is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods.
BlackRock provides compensation in connection with obtaining or using third-party ratings, rankings, or data.
Performance data represents past performance and does not guarantee future results. Investment return and principal value will fluctuate with market conditions and may be lower or higher when you sell your shares. Current performance may differ from the performance shown. For most recent month-end performance and standardized performance, click on the fund name above.
The Morningstar RatingTM for funds, or "star rating", is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods.
BlackRock provides compensation in connection with obtaining or using third-party ratings, rankings, or data.
Performance data represents past performance and does not guarantee future results. Investment return and principal value will fluctuate with market conditions and may be lower or higher when you sell your shares. Current performance may differ from the performance shown. For most recent month-end performance and standardized performance, click on the fund name above.
Systematic investing, often called quantitative investing, is an investment approach that emphasizes data-driven insights, scientific testing of investment ideas, and advanced computer modelling techniques to construct portfolios.
BlackRock’s systematic strategies are designed to deliver investment solutions for the whole portfolio. They are built on the underlying principle of leveraging data and technology to seek differentiated excess returns, diversification, and robust risk management—all at a reasonable cost to investors.
Source: BlackRock as of 12/31/2023
BlackRock as of 1/1/2024
Explore BlackRock’s full platform of active equity solutions to address your clients’ needs.
| Ticker | Name | ETF or mutual fund? | Morningstar category | Overall Morningstar Rating | 1-yr Morningstar percentile ranking† | 3-yr Morningstar percentile ranking† | 5-yr Morningstar percentile ranking† | 10-yr Morningstar percentile ranking† | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. | ||||||||||||||
| MADVX | Equity Dividend | Mutual fund | Large value | 4 | 39 | 62 | 47 | 30 | ||||||
| MAFOX | Large Cap Focus Growth | Mutual fund | Large growth | 2 | 8 | 72 | 42 | 25 | ||||||
| MARFX | Mid-Cap Value | Mutual fund | Mid cap value | 3 | 54 | 41 | 16 | 25 | ||||||
| CMGIX | Mid-Cap Growth | Mutual fund | Mid cap growth | 2 | 10 | 72 | 49 | 7 | ||||||
| BIRIX | Sustainable Large Cap Core | Mutual fund | Large blend | 3 | 38 | 50 | 17 | N/A | ||||||
| BROIX | Advantage International | Mutual fund | Foreign large blend | 5 | 13 | 6 | 21 | 14 | ||||||
| BLCV | BlackRock Large Cap Value ETF | ETF | Large value | N/A | N/A | N/A | N/A | |||||||
| BALI | BlackRock Advantage Large Cap Income ETF | ETF | Derivative Income | N/A | N/A | N/A | N/A | |||||||
| DYNF | BlackRock U.S. Equity Factor Rotation ETF | ETF | Large blend | 4 | 3 | 8 | 32 | N/A | ||||||
| International/Emerging Markets | ||||||||||||||
| MADCX | Emerging Markets | Mutual fund | Diversified EM | 3 | 55 | 65 | 30 | 21 | ||||||
| MAILX | International Fund | Mutual fund | Foreign large blend | 1 | 10 | 89 | 9 | 37 | ||||||
| BISIX | International Dividend Fund | Mutual fund | Foreign large blend | 5 | 65 | 5 | 9 | 68 | ||||||
| Thematics | ||||||||||||||
| SHSSX | Health Sciences Opportunities | Mutual fund | Health | 4 | 44 | 28 | 30 | 7 | ||||||
| BGSIX | Technology Opportunities | Mutual fund | Technology | 2 | 43 | 68 | 32 | 32 | ||||||
| Income | ||||||||||||||
| BMCIX | High Equity Income | Mutual fund | Derivative Income | 4 | 65 | 5 | 9 | 68 | ||||||
Overall Morningstar Ratings as of 6/30/2024. Ratings are based on risk adjusted total returns, are determined monthly and are subject to change.
Equity Dividend Fund rated against 1,099 Large Value Funds; Large Cap Focus Growth rated against 1,092 Large Growth Funds. Mid-Cap Value rated against 374 Mid-Cap Value Funds. Mid-Cap Growth rated against 510 Mid-Cap Growth Funds. Sustainable Advantage Large Cap Core rated against 1,302 US Large Blend funds. Advantage International rated against 679 Foreign Large Blends funds. U.S. Equity Factor Rotation ETF rated against 1,302 US Large Blends funds. Emerging Markets Fund rated against 718 Diversified Emerging Markets Funds. International Fund rated against 338 US Fund Foreign Large Blend funds. International Dividend rated against 679 Foreign Large Blend Funds. Health Sciences Opportunities Fund rated against 161 Health Funds. Technology Opportunities rated against 231 Technology Funds. High Equity Income rated against 71 Derivative Income Funds.
As of 6/30/2024, the Equity Dividend Fund received a Morningstar Rating of 3 stars for the 3-year period, 3 stars for the 5-year period and 4 stars for the 10-year period, rated against 1,099, 1,035 and 809 Large Value Funds, respectively. The Large Cap Focus Growth Fund received a Morningstar Rating of 2 stars for the 3-year period, 3 stars for the 5-year period and 4 stars for the 10-year period, rated against 1,092, 1,019 and 794 Large Growth Funds, respectively. Mid-Cap Value Fund received a Morningstar Rating of 4 stars for the 3-year period, 4 stars for the 5-year period and 4 stars for the 10-year period, rated against 374, 360 and 281 Mid-Cap Value Funds, respectively. The Mid-Cap Growth Equity Fund received a Morningstar Rating of 2 stars for the 3-year period, 2 stars for the 5-year period and 4 stars for the 10-year period, rated against 510, 473 and 380 Mid-Cap Growth Funds, respectively. The Sustainable Large Cap Core Fund received a Morningstar Rating of 3 stars for the 3-year period and 4 stars for the 5-year period, rated against 1,302 and 1,192 Large Blend Funds, respectively. The Advantage International received a Morningstar Rating of 5 stars for the 3-year period, 4 stars for the 5-year period and 4 stars for the 10-year period, rated against 679, 639 and 421 US Foreign Large Blend Funds, respectively. The U.S. Equity Factor Rotation ETF received a Morningstar Rating of 5 stars for the 3-year period, 4 stars for the 5-year period and 0 stars for the 10-year period, rated against 1,302, 1,192 and 888 Diversified Emerging Mkts Funds, respectively. The Emerging Markets Fund received a Morningstar Rating of 2 stars for the 3-year period, 3 stars for the 5-year period and 423 stars for the 10-year period, rated against 718, 646 and 423 Diversified Emerging Mkts Funds, respectively. The International Fund received a Morningstar Rating of 3 star for the 3-year period, 4 stars for the 5-year period and 4 stars for the 10-year period, rated against 338, 320 and 240 Foreign Large Blend Funds, respectively. The International Dividend received a Morningstar Rating of 5 stars for the 3-year period, 5 stars for the 5-year period and 4 stars for the 10-year period, rated against 679, 639 and 421 US Foreign Large Blend Funds, respectively. The Health Sciences Opportunities Fund received a Morningstar Rating of 4 stars for the 3-year period, 4 stars for the 5-year period and 5 stars for the 10-year period, rated against 161, 139 and 114 Health Funds, respectively. The Technology Opportunities Fund received a Morningstar Rating of 3 stars for the 3-year period, 3 stars for the 5-year period and 4 stars for the 10-year period, rated against 231, 201 and 155 Technology Funds, respectively. The High Equity Income Fund received a Morningstar Rating of 3 stars for the 3-year period, 3 stars for the 5-year period and 3 stars for the 10-year period, rated against 71, 65 and 37 Options-based Funds, respectively.
Performance results represent past performance and are no guarantee of future results.
Performance data represents past performance and does not guarantee future results. Investment return and principal value will fluctuate with market conditions and may be lower or higher when you sell your shares. Current performance may differ from the performance shown. For most recent month-end performance and standardized performance, click on the fund names above.
† Source: Equity Dividend: 1 Year 765/1,180; 3 Year 649/1,099; 5 Year 500/1,035; 10 Year 179/809. Large Cap Focus Growth: 1 Year 225/1,162; 3 Year 575/1,092; 5 Year 447/1,019; 10 Year 101/794. Mid-Cap Value: 1 Year 259/392; 3 Year 161/374; 5 Year 60/360; 10 Year 75/281. Mid-Cap Growth Equity: 1 Year 281/531; 3 Year 372/510; 5 Year 349/473; 10 Year 51/380. Sustainable Advantage Large Cap Core: 1 Year 326/1,415; 3 Year 564/1,302; 5 Year 188/1,192; 10 Year /888. Advantage International: 1 Year 136/734; 3 Year 35/679; 5 Year 126/639; 10 Year 39/421. Emerging Markets: 1 Year 648/804; 3 Year 522/718; 5 Year 325/646; 10 Year 129/423. International Fund: 1 Year 103/351; 3 Year 240/338; 5 Year 58/320; 10 Year 50/240. International Dividend: 1 Year 486/734; 3 Year 26/679; 5 Year 64/639; 10 Year 138/421. Health Sciences Opportunities: 1 Year 57/176; 3 Year 44/161; 5 Year 34/139; 10 Year 3/114. Technology Opportunities: 1 Year 62/263; 3 Year 151/231; 5 Year 82/201; 10 Year 41/155. High Equity Income: 1 Year 56/90; 3 Year 31/71; 5 Year 22/65; 10 Year 8/37.
Ratings based on risk-adjusted total return, determined monthly and subject to change.
The Morningstar Rating for funds, or "star rating," is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods.
Read the latest from our BlackRock active portfolio managers and experts on what they’re seeing in the markets and advisor portfolios.
Carefully consider the Funds' investment objectives, risk factors, and charges and expenses before investing. This and other information can be found in the Funds' prospectuses or, if available, the summary prospectuses which may be obtained visiting the iShares ETF and BlackRock Mutual Fund prospectus pages. Read the prospectus carefully before investing.
The Morningstar Medalist RatingTM is the summary expression of Morningstar’s forward-looking analysis of investment strategies as offered via specific vehicles using a rating scale of Gold, Silver, Bronze, Neutral, and Negative. The Medalist Ratings indicate which investments Morningstar believes are likely to outperform a relevant index or peer group average on a risk-adjusted basis over time. Investment products are evaluated on three key pillars (People, Parent, and Process) which, when coupled with a fee assessment, forms the basis for Morningstar’s conviction in those products’ investment merits and determines the Medalist Rating they’re assigned. Pillar ratings take the form of Low, Below Average, Average, Above Average, and High. Pillars may be evaluated via an analyst’s qualitative assessment (either directly to a vehicle the analyst covers or indirectly when the pillar ratings of a covered vehicle are mapped to a related uncovered vehicle) or using algorithmic techniques. Vehicles are sorted by their expected performance into rating groups defined by their Morningstar Category and their active or passive status. When analysts directly cover a vehicle, they assign the three pillar ratings based on their qualitative assessment, subject to the oversight of the Analyst Rating Committee, and monitor and reevaluate them at least every 14 months. When the vehicles are covered either indirectly by analysts or by algorithm, the ratings are assigned monthly. For more detailed information about these ratings, including their methodology, please go to global.morningstar.com/managerdisclosures/.
The Morningstar Medalist Ratings are not statements of fact, nor are they credit or risk ratings. The Morningstar Medalist Rating (i) should not be used as the sole basis in evaluating an investment product, (ii) involves unknown risks and uncertainties which may cause expectations not to occur or to differ significantly from what was expected, (iii) are not guaranteed to be based on complete or accurate assumptions or models when determined algorithmically, (iv) involve the risk that the return target will not be met due to such things as unforeseen changes in management, technology, economic development, interest rate development, operating and/or material costs, competitive pressure, supervisory law, exchange rate, tax rates, exchange rate changes, and/or changes in political and social conditions, and (v) should not be considered an offer or solicitation to buy or sell the investment product. A change in the fundamental factors underlying the Morningstar Medalist Rating can mean that the rating is subsequently no longer accurate.
Investing involves risks, including possible loss of principal.
Past performance is no guarantee of future results.
The BlackRock funds are actively managed and their characteristics will vary.
Stock and bond values fluctuate in price so the value of your investment can go down depending on market conditions.
International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks may be heightened for investments in emerging markets. Asset allocation and diversification strategies do not ensure profit or protect loss in declining markets.
Prepared by BlackRock Investments, LLC, member FINRA.
©2024 BlackRock, Inc. or its affiliates. All Rights Reserved. BLACKROCK, BLACKROCK SOLUTIONS, BUILD ON BLACKROCK, ALADDIN, iSHARES, iBONDS, FACTORSELECT, iTHINKING, iSHARES CONNECT, FUND FRENZY, LIFEPATH, SO WHAT DO I DO WITH MY MONEY, INVESTING FOR A NEW WORLD, BUILT FOR THESE TIMES, the iShares Core Graphic, CoRI and the CoRI logo are trademarks of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners.
USRRMH0524U/S-3548028
